NCT01001871

Brief Summary

Iron deficiency and iron deficiency anemia (IDA) are the most prevalent micronutrient deficiencies on a worldwide basis, especially in developing countries. The impact of severe IDA can have mortal consequences, since without adequate hemoglobin, the brain and body become deprived of oxygen and, if allowed to continue, death may ensue. It has been shown that iron supplementation in infants and young children can enhance child development, however, it may also result in increased rates of malaria in high burden areas. The primary objective of this study is to determine the impact of providing encapsulated iron (as a powder added to complementary foods) on the susceptibility to clinical malaria among anemic and non-anemic infants and young children (6-24 months of age) living in a high malaria burden area. The value of performing this research in Ghana is primarily that malaria and anemia remain the most important causes of death and morbidity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,880

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2009

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 21, 2009

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 27, 2009

Completed
5 days until next milestone

Study Start

First participant enrolled

November 1, 2009

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2010

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2011

Completed
Last Updated

April 19, 2021

Status Verified

April 1, 2021

Enrollment Period

11 months

First QC Date

October 21, 2009

Last Update Submit

April 14, 2021

Conditions

Keywords

Iron deficiency anemiaSprinkles®micronutrientsmalaria incidenceiron supplement

Outcome Measures

Primary Outcomes (1)

  • incidence of clinical malaria (if fever recorded a blood sample will be taken to determine parasite species and count)

    5 months

Secondary Outcomes (8)

  • changes in anemia status (blood levels of: haemoglobin(Hb) , ferritin (SF))

    5 months

  • severity of clinical malaria (blood parasite count)

    5 months

  • cerebral malaria (defined by a parasite count >5000/μL blood and a concurrent score of <2 on the Blantyre coma scale, with or without convulsions)

    5 months

  • hospitalization (documentation of hospitalization for any reason)

    5 months

  • death

    5 months

  • +3 more secondary outcomes

Study Arms (2)

Vitamin/mineral fortificant with iron

EXPERIMENTAL
Dietary Supplement: Sprinkles®

Vitamin/mineral fortificant without iron

PLACEBO COMPARATOR
Dietary Supplement: vitamin/mineral fortificant without iron

Interventions

Sprinkles®DIETARY_SUPPLEMENT

powdered vitamin/mineral fortificant WITH iron sprinkled onto food once a day for 5 months

Vitamin/mineral fortificant with iron

powdered vitamin/mineral fortificant WITHOUT iron sprinkled onto food once a day for 5 months

Vitamin/mineral fortificant without iron

Eligibility Criteria

Age6 Months - 24 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Age 6-24 months
  • Ingesting weaning food in addition to breastmilk
  • Free from malaria or other major illnesses
  • Afebrile
  • Living in Brong Ahafo Region of Ghana for duration of intervention and follow-up

You may not qualify if:

  • Severe anemia (hemoglobin \<70g/L)
  • Weight-for-height \<-3 z-score(severe wasting)
  • Kwashiorkor (defined as evidence of edema)
  • Congenital abnormality
  • Treatment with iron supplements within the past 6 months
  • Presence of any chronic illness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kintampo Health Research Centre

Kintampo, PO Box 200, Ghana

Location

Related Publications (5)

  • Tchum SK, Sakyi SA, Arthur F, Adu B, Abubakar LA, Oppong FB, Dzabeng F, Amoani B, Gyan T, Asante KP. Effect of iron fortification on anaemia and risk of malaria among Ghanaian pre-school children with haemoglobinopathies and different ABO blood groups. BMC Nutr. 2023 Mar 23;9(1):56. doi: 10.1186/s40795-023-00709-w.

  • Tchum SK, Sakyi SA, Adu B, Arthur F, Oppong FB, Dzabeng F, Amoani B, Gyan T, Poku-Asante K. Impact of IgG response to malaria-specific antigens and immunity against malaria in pre-school children in Ghana. A cluster randomized, placebo-controlled trial. PLoS One. 2021 Jul 20;16(7):e0253544. doi: 10.1371/journal.pone.0253544. eCollection 2021.

  • Aimone AM, Brown P, Owusu-Agyei S, Zlotkin SH, Cole DC. Impact of iron fortification on the geospatial patterns of malaria and non-malaria infection risk among young children: a secondary spatial analysis of clinical trial data from Ghana. BMJ Open. 2017 Jun 6;7(5):e013192. doi: 10.1136/bmjopen-2016-013192.

  • Aimone AM, Brown PE, Zlotkin SH, Cole DC, Owusu-Agyei S. Geo-spatial factors associated with infection risk among young children in rural Ghana: a secondary spatial analysis. Malar J. 2016 Jul 8;15:349. doi: 10.1186/s12936-016-1388-1.

  • Zlotkin S, Newton S, Aimone AM, Azindow I, Amenga-Etego S, Tchum K, Mahama E, Thorpe KE, Owusu-Agyei S. Effect of iron fortification on malaria incidence in infants and young children in Ghana: a randomized trial. JAMA. 2013 Sep 4;310(9):938-47. doi: 10.1001/jama.2013.277129.

MeSH Terms

Conditions

AnemiaAnemia, Iron-Deficiency

Interventions

VitaminsIron

Condition Hierarchy (Ancestors)

Hematologic DiseasesHemic and Lymphatic DiseasesAnemia, HypochromicIron DeficienciesIron Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

MicronutrientsPhysiological Effects of DrugsPharmacologic ActionsChemical Actions and UsesNutrientsFoodDiet, Food, and NutritionPhysiological PhenomenaFood and BeveragesMetals, HeavyElementsInorganic ChemicalsTransition ElementsMetals

Study Officials

  • Stanley H Zlotkin, PhD

    The Hospital for Sick Children, Toronto, Canada

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief, Global Child Health

Study Record Dates

First Submitted

October 21, 2009

First Posted

October 27, 2009

Study Start

November 1, 2009

Primary Completion

October 1, 2010

Study Completion

May 1, 2011

Last Updated

April 19, 2021

Record last verified: 2021-04

Locations